BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27322554)

  • 1. Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction.
    Ge Z; Gu Y; Xiao L; Han Q; Li J; Chen B; Yu J; Kawasawa YI; Payne KJ; Dovat S; Song C
    Oncotarget; 2016 Jul; 7(29):46014-46027. PubMed ID: 27322554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia.
    Ge Z; Zhou X; Gu Y; Han Q; Li J; Chen B; Ge Q; Dovat E; Payne JL; Sun T; Song C; Dovat S
    Oncotarget; 2017 Jan; 8(5):8022-8034. PubMed ID: 28030830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
    Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
    Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia.
    Ge Z; Gu Y; Han Q; Sloane J; Ge Q; Gao G; Ma J; Song H; Hu J; Chen B; Dovat S; Song C
    Epigenomics; 2018 Jan; 10(1):59-69. PubMed ID: 28994305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.
    Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S
    Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.
    Song C; Ge Z; Ding Y; Tan BH; Desai D; Gowda K; Amin S; Gowda R; Robertson GP; Yue F; Huang S; Spiegelman V; Payne JL; Reeves ME; Gurel Z; Iyer S; Dhanyamraju PK; Xiang M; Kawasawa YI; Cury NM; Yunes JA; McGrath M; Schramm J; Su R; Yang Y; Zhao Z; Lyu X; Muschen M; Payne KJ; Gowda C; Dovat S
    Blood; 2020 Sep; 136(13):1520-1534. PubMed ID: 32396934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
    Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
    Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.
    Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S
    J BUON; 2014; 19(1):22-8. PubMed ID: 24659638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.
    Gowda C; Song C; Kapadia M; Payne JL; Hu T; Ding Y; Dovat S
    Adv Biol Regul; 2017 Jan; 63():71-80. PubMed ID: 27666503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia.
    Payne JL; Song C; Ding Y; Dhanyamraju PK; Bamme Y; Schramm JW; Desai D; Sharma A; Gowda C; Dovat S
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia.
    Ge Z; Gu Y; Han Q; Zhao G; Li M; Li J; Chen B; Sun T; Dovat S; Gale RP; Song C
    Sci Rep; 2016 Nov; 6():38004. PubMed ID: 27885263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
    Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
    PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia.
    Bond J; Domaschenz R; Roman-Trufero M; Sabbattini P; Ferreiros-Vidal I; Gerrard G; Asnafi V; Macintyre E; Merkenschlager M; Dillon N
    Oncotarget; 2016 Oct; 7(40):65923-65936. PubMed ID: 27588474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
    Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
    J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
    Sun L; Heerema N; Crotty L; Wu X; Navara C; Vassilev A; Sensel M; Reaman GH; Uckun FM
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):680-5. PubMed ID: 9892693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
    Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
    J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.
    Dhanyamraju PK; Iyer S; Smink G; Bamme Y; Bhadauria P; Payne JL; Dovat E; Klink M; Ding Y
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.
    Dovat E; Song C; Hu T; Rahman MA; Dhanyamraju PK; Klink M; Bogush D; Soliman M; Kane S; McGrath M; Ding Y; Desai D; Sharma A; Gowda C
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ikaros and tumor suppression in acute lymphoblastic leukemia.
    Payne KJ; Dovat S
    Crit Rev Oncog; 2011; 16(1-2):3-12. PubMed ID: 22150303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing of Ikaros regulates the FUT4/Le
    Yi L; Hu Q; Zhou J; Liu Z; Li H
    Biochem Biophys Res Commun; 2019 Feb; 510(1):128-134. PubMed ID: 30683310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.